Zum Inhalt

Possible role of ribosome biogenesis in the recovery from transient hepatic damage caused by ethylene glycol in rats

  • Open Access
  • 03.02.2026
  • Original Article

Abstract

Purpose

Ethylene glycol (EG), a widely used industrial compound, has been implicated in accidental poisoning and homicide. Although the nephrotoxic mechanisms of EG are well characterized, its acute hepatotoxic potential remains underexplored. This study investigated histopathological and molecular alterations in the liver of rats following acute administration of EG. Possible dysfunction of an anti-oxidative pathway involving ferroptosis (glutathione peroxidase 4, Gpx4; solute carrier family 7 member 11, SLC7A11) is also examined.

Methods

Male rats (8-week-old, male) were orally administered EG (8 g/kg) and euthanized at 2 and 5 days post-exposure by an administration of an overdose of anesthetic (40 mg/kg sodium pentobarbital). Serological analysis was performed to assess liver function. Liver tissues were evaluated by histology, transmission electron microscopy, and transcriptome analysis.

Results

Serological findings indicated transient liver damage at 2 days post-exposure, followed by recovery at 5 days. Transmission electron microscopy revealed glycogen accumulation, corroborated by periodic acid–Schiff and periodic acid-methenamine silver staining. Histological analysis revealed an increased number of nucleoli, correlating with upregulation of ribosomal genes on microarray analysis, particularly at 5 days post-exposure. In addition, significant decreases in Gpx4 and SLC7A11 expression were observed in rat livers treated with EG and Huh-7 human hepatoma cells, suggesting reduced cellular antioxidative capacity as a contributing factor to transient liver damage.

Conclusions

These findings reveal a pathway underlying EG-induced transient liver damage and suggest a possible mechanism of recovery, thereby providing new insights into EG poisoning.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1007/s11419-026-00757-4.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Ethylene glycol (EG) is a widely used industrial solvent found in antifreeze, coolants, de-icing agents, and household products, such as cold packs and paints [1]. While generally safe when used as intended, EG possesses high toxicity and has occasionally been implicated in both accidental and intentional poisoning [25]. Once ingested, EG is rapidly absorbed from the gastrointestinal tract, reaching peak blood concentrations within 2–6 h [6]. Acute toxicity of EG is generally consisted of three stages; manifestations of 1) CNS depression such as confusion and somnolence after several hours, 2) cardiopulmonary disfunctions such as heart failure after half-to-one day, and 3) renal failures after several days from EG ingestion [3, 7]. Approximately 80% of ingested EG is metabolized in the liver by alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH), producing toxic metabolites, such as glycolaldehyde, glycolic acid (GA), and glyoxylic acid [8, 9]. These metabolites, rather than the parent compound, are the principal mediators of toxicity. In particular, GA and oxalic acid contribute to severe metabolic acidosis and calcium oxalate (CaOx) crystal deposition in tissues, most notably the kidney [10, 11].
Although nephrotoxicity is the most recognized outcome of EG poisoning, with CaOx crystals causing acute tubular necrosis and often acute kidney injury (AKI), EG toxicity is not confined to the kidney. CaOx crystals may also deposit in the liver, heart, lungs, central nervous system, and gastrointestinal mucosa [12, 13]. For example, liver degeneration, such as swollen mitochondria and centrilobular necrosis, has been reported in an animal model of EG poisoning [14, 15]. Nevertheless, both human and animal studies have demonstrated that renal CaOx crystals are not always detected—even in lethal cases or in those with high urinary GA concentrations [16]. This discrepancy highlights the need for a broader understanding of EG-induced tissue injury beyond crystal deposition alone.
Despite the established nephrotoxic mechanisms, the hepatic effects of EG remain underexplored, even though the liver is its principal site of metabolism. Moreover, the molecular responses of hepatocytes to EG metabolites—including alterations in metabolic enzymes and solute transporter expression—are poorly characterized. Therefore, this study aimed to investigate the acute hepatic histopathological and transcriptomic alterations following EG exposure in a rat model, with findings further validated in human hepatoma (Huh-7) cells.

Materials and methods

Animals and EG administration

All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Institute of Science Tokyo (ST) (approval No. A2023-080C) and conducted in accordance with the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines [17, 18]. Eight-week-old male Wistar rats (220–250 g; Oriental Yeast Co. Ltd., Tokyo, Japan) were housed under standardized conditions (12-h light/dark cycle, 25 °C) with free access to food and water. The rats were randomly assigned to either the control or the EG-treated group. Each animal received a single oral dose of either 0.9% NaCl (control) or 8 or 16 g/kg EG (Fujifilm Wako Pure Chemical Corporation, Osaka, Japan). Samples were collected at 2 or 5 days after administration of EG (EG2 or EG5, respectively), after euthanasia with an overdose of sodium pentobarbital (40 mg/kg). Each group consisted of 6 male rats, with 3–5 animals per group used for each specific analysis. The 8 g/kg EG dose was selected based on a previous study investigating acute EG toxicity [19].

Cell culture and EG administration

The Huh-7 human hepatoma cell line (RCB1366, RIKEN Bioresources Center, Tsukuba, Japan) was used as an in vitro model of EG-induced hepatotoxicity. Cells were maintained in Dulbecco’s Modified Eagle Medium supplemented with 10% fetal bovine serum, 100 μg/mL streptomycin, and 100 U/mL penicillin. EG concentrations (0.3, 0.6, and 1.2 M) were selected based on a previous report [20], in which the IC50 of EG on the viability of KB (HeLa derivative) cells was estimated at 0.45 M. Cell viability was measured using the Cell Counting Kit-8 (Dojindo, Kumamoto, Japan).

Blood analysis

Blood samples (anticoagulant: 1.5 mg/mL K3-EDTA) were collected from the rats at 2 and 5 days after EG administration (8 g/kg). Plasma levels of albumin (ALB), aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), and γ-glutamyl transpeptidase (γ-GTP) were measured according to the standard clinical chemistry methods (Oriental Yeast Co., Ltd., Tokyo, Japan). Blood samples collected prior to organ harvesting on days 2 and 5 were immediately analyzed for pH, bicarbonate (HCO₃⁻), and anion gap (AG) using the i-STAT®1 analyzer with EC8 + cartridges (Abbott Point of Care Inc., Princeton, NJ, USA).

Histological analysis, immunohistochemistry, and electron microscopy

Rat liver tissues were fixed in 4% paraformaldehyde, embedded in paraffin, and sliced into 2.5 µm sections. For histological analysis, the sections were stained with hematoxylin and eosin (H&E). Transmission electron microscopy (TEM) of rat liver was performed according to previously described methods [21, 22]. Briefly, approximately 1 mm3 of liver tissue was fixed in 2.5% glutaraldehyde, post-fixed in 1% osmium tetroxide, and embedded in epoxy resin (EPON). Ultrathin Sects. (80 nm) were stained with uranyl acetate and lead citrate and examined using a transmission electron microscope (HT7800, Hitachi High-Tech Co., Tokyo, Japan). Semi-thin Sects. (0.5 μm) of EPON-embedded tissue, prepared prior to ultrathin sectioning for TEM, were stained with toluidine blue and observed under both bright-field and dark-field microscopy. To visualize glycogen, periodic acid–Schiff (PAS) and periodic acid-methenamine silver (PAM) staining were performed after removing epoxy resin from EPON-embedded sections using a saturated KOH solution. Oil Red O staining of frozen sections was also conducted to visualize lipid droplets.

DNA microarray and qPCR analysis

Total RNA from the livers of rats treated with or without EG was subjected to Clariom S array analysis (Thermo Fisher Scientific, Waltham, MA). Prior to analysis, RNA was purified using RNeasy Mini Kit (QIAGEN, Hilden, Germany), and RNA integrity was verified using a Bioanalyzer (Agilent, Santa Clara, CA). Transcriptome Analysis Console software (Thermo Fisher Scientific) was used for pathway enrichment analysis, and Metascape (https://metascape.org/gp/index.html#/main/step1) [23] was used for gene ontology (GO) enrichment analysis. Relative mRNA levels were measured using reverse transcription-quantitative PCR (RT-qPCR). Briefly, total RNA extracted from rat liver or Huh-7 cells using TRIzol reagent (Thermo Fisher Scientific) was used for cDNA synthesis. SuperScript II reverse transcriptase (Thermo Fisher Scientific) and oligo(dT)15 primers were used to synthesize cDNA from total RNA. Gene-specific primers (Table S1), SYBR Green dye (Promega, Madison, WI), and the StepOne real-time PCR system (Thermo Fisher Scientific) were used for qPCR. Relative mRNA abundances were calculated using the comparative Ct method [24].

Immunoblot analysis

Rat liver tissues were immersed in lysis buffer [10 mM Tris–HCl (pH 8.0), 320 mM sucrose, 1 mM EDTA, 50 mM NaF, 2 mM Na3VO4, and protease inhibitor cocktail (Complete; Roche, Mannheim, Germany)] together with magnetic beads and disrupted using a bead crusher [3000 revolutions per minutes (rpm) for 10 s at room temperature, 3 cycles] (Multi-beads Shocker MB3000, Yasui Kikai, Osaka, Japan). The homogenates were centrifuged at 20,000 × g for 15 min to remove debris. Laemmli’s buffer was added to the supernatant [final composition is 0.06 M Tris–HCl (pH 6.8), 2% SDS, 3% 2-mercaptoethanol, 10% glycerol, and 0.005% BPB]. Huh-7 cells were collected in the Laemmli’s buffer, and lysates were obtained via sonication (Output, 40 kHz; Pulse Setting, continuous; Duration, 10 s; Temperature, room temperature) (SFX150HH, Branson, Brookfield, CT). The tissue as well as cell lysates were subjected to SDS-PAGE (15% gels for Gpx4, SLC7A11, GAPDH, phospho-eIFα, and eIFα; 10% gels for 4-hydroxy-2-nonenal) by the method of Laemmli [25], and transferred on to a PVDF membrane (Immobilon-P, Millipore, Billerica, MA) by the method of Towbin et al. [26]. Just before the use, PVDF membranes were activated through immersion in methanol for at least 20 min. For the analysis of 4-hydroxy-2-nonenal, lysates were subjected to SDS-PAGE in discontinuous (4–15%) gels (Mini-PROTEAN-TGX precast gel; Bio-Rad, Hercules, CA). The blots were blocked with 5% non-fat dry milk in Tris-buffered saline containing 0.05% Tween 20 for 30 min at room temperature (RT), then incubated with appropriate antibodies (Table S2) over night at 4 °C. The membranes were subsequently incubated with horseradish peroxidase-conjugated anti-IgG antibodies (Promega) for 30 min at RT and visualized using enhanced chemiluminescence (ECL) reagents (Western Lightning Plus, Revvity, Waltham, MA). Band intensities were quantified using Image Capture version 4 (ATTO, Tokyo, Japan).

Statistical analysis

Dunnett’s (for comparisons vs. a control) or Tukey–Kramer (for all pairwise comparisons) post hoc test was used for multiple group comparisons. Two-tailed P values < 0.05 were considered statistically significant. Statistical analyses were performed using GraphPad Prism, version 9.0.0 (GraphPad Software, San Diego, CA, USA).

Results

Possible liver damage in EG-administered rats

We applied 8 and 16 g/kg EG orally to rats to assess the maximum sublethal toxicity, since the LD50 of EG was estimated at 6.1–13 g/kg when administered orally to rats [8]. Both rats (2 out of 2, 100%) died 1 day after the administration of 16 g/kg EG. In contrast, a total of 6 out of 8 (75%) rats survived 5 days after the administration of 8 g/kg EG. All the rats administered saline (5 out of 5) survived after the experiments. Based on these findings, 8 g/kg EG was used throughout this study. To examine EG-induced liver damage in animal models, livers were dissected from rats at 2 and 5 days after administration. Although no significant changes in body weight were observed, liver weights decreased by approximately one-half at 5 days post-EG administration (Table 1). Consistent with the decline in liver weights, which indicated liver damage, metabolic acidosis was observed in EG-administered rats, evidenced by a significant decline in blood pH, a tendency toward decreased HCO3 concentrations, and a significant elevation in serum AG (Table 1). Taken together, these findings indicate liver damage in EG-administered rats, as evidenced by organ weight loss and metabolic acidosis.
Table 1
Loss of liver weight and metabolic acidosis after ethylene glycol (EG) administration
 
Control
EG2
EG5
Body Weight (g)
289.5 ± 12.2
265.7 ± 10.5
281.7 ± 9.6
Liver Weight (g)
12.87 ± 0.98
12.59 ± 0.70 **** (vs EG5)
7.80 ± 0.22 **** (vs Control)
pH
7.573 ± 0.162
6.942 ± 0.083 ** (vs Control)
6.878 ± 0.183 ** (vs Control)
HCO3 (mmol/L)
19.93 ± 5.75
12.73 ± 3.70
10.80 ± 3.32
AG (mEq/L)
26.40 ± 6.43
44.60 ± 2.36
48.20 ± 12.47 * (vs Control)
AST (IU/L)
94.4 ± 23.6
363.5 ± 257.1 * (vs Control)
231.8 ± 33.6
ALT (IU/L)
26.6 ± 1.7
82.8 ± 28.8 ** (vs Control)
44.8 ± 8.4 * (vs EG2)
LDH (IFCC) (IU/L)
214.6 ± 96.7
2172.8 ± 1051.4 ** (vs Control)
1461.5 ± 259.6 * (vs Control)
After 12 h of fasting, 8-week-old male Wistar rats received a single oral dose of 8 g/kg EG or an equal volume of saline (0.9% NaCl) and were euthanized 2 or 5 days later. Whole body and liver weights 2 and 5 days after EG administration and blood sample analysis. Sample sizes were as follows: body weight and liver weight, n = 6 per group; pH, HCO3, and AG, n = 3 per group; AST, ALT, and LDH, Control (n = 5), EG2 (n = 4), and EG5 (n = 4). The means ± S.D. are shown. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. AG, anion gap

Transient liver injuries in EG-administered rats

Serological markers were examined to evaluate liver injury in EG-administered rats. Significant increases in AST, ALT, and LDH were observed at 2 days after EG administration (EG2 group), followed by a significant decrease in ALT and declining trends in AST and LDH in the EG5 group compared with the EG2 group (Table 1), as shown schematically in Fig. 1. Although changes were modest, similar tendencies were also noted in ALB, ALP, and γ − GT, suggesting transient (Supplementary Fig. S1) liver injury that peaked at 2 days and recovered by 5 days after EG administration.
Fig. 1
Transient liver damage after EG administration. After 12 h of fasting, 8-week-old Wistar rats received a single oral dose of 8 g/kg EG or an equal volume of saline (0.9% NaCl) and were euthanized 2 or 5 days later. Blood analysis results are shown. Each bar represents the mean ± S.D. ns, not significant; *P < 0.05; **P < 0.01. AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase
Bild vergrößern

Histology of EG-administered rat liver

Microscopic examination of livers from EG-administered rats was conducted to identify histological features of EG-induced hepatotoxicity (Supplementary Fig. S2).
In the kidney from the EG2 group, congestion and large vacuole-like structures were observed in the cytoplasm compared with the control group (Supplementary Fig. S2A, b and e). Although nuclear morphology showed no apparent differences (Supplementary Fig. S2A, b and e), an increased number of cells contained multiple nucleoli per nucleus (Supplementary Fig. S2B).
In the kidney from the EG5 group, lesser congestion and vacuole-like structures were observed in the cytoplasm compared with the EG5 group (Supplementary Fig. S2A, c and f). As shown in Supplementary Fig. S2, the occurrence of nuclei with multiple nucleoli was significantly increased compared with that in controls (Supplementary Fig. S2B).

Electron microscopic analysis of EG-administered rat liver

To further examine the degenerative changes observed in EG-administered rat livers, electron microscopy was performed.
In the kidney from the EG2 group, the most notable finding was that hepatocyte cytoplasm contained regions of low electron density, suggestive of fluid accumulation in localized cytoplasmic areas (Fig. 2, b, e, and h). Closer inspection of these regions revealed 10–30 nm granule-like structures, consistent in size with glycogen (Fig. 2, h). Although mitochondria and ER appeared displaced to peripheral areas of the cytoplasm, no apparent mitochondrial degeneration was observed (Fig. 2, e). In contrast, the proportion of rough ER relative to total ER volume increased compared with that in controls (Fig. 2, e).
Fig. 2
Transmission electron microscopy (TEM) of liver sections from EG-administered rats. TEM images of liver sections from control rats (control, a, d, g) and EG-treated rats 2 (EG2, b, e, h) or 5 (EG5, c, f, i) days after EG administration (8 g/kg). Bars: 5 µm (a–c), 500 nm (d–f), and 100 nm (g–i)
Bild vergrößern
In the kidney from the EG5 group, restoration of these observations (fluid accumulation as well as increased proportion of rough ER observed in the EG2 group) to basal levels was observed (Fig. 2, c, f, and i).

PAS, PAM, and Oil Red O staining of EG-administered rat liver

To further evaluate the low electron density region observed in the liver of the EG2 group, TEM, PAS, PAM, and Oil Red O staining were performed.
In the kidney from the EG2 group, both PAS and PAM staining showed typical glycogen staining patterns in the hepatic cytoplasm (Supplementary Fig. S3A, b and e), confirming that the granules observed by TEM (Fig. 2, h) were glycogen granules. Oil Red O staining did not stain the hepatocytes, excluding the possibility that the area contained lipids (Supplementary Fig. S3A, h). In addition, we observed crystals in the kidney from EG2 group (Supplementary Fig. S3B).
In the kidney from the EG5 group, restoration of these observations (accumulation of glycogens as well as crystals observed in the EG2 group) to basal levels was observed (Supplementary Fig. S3A, c and f).

Bright- and dark-field microscopic observations after toluidine blue staining of EG-administered rat liver

Toluidine blue staining, which does not stain glycogen, was applied to liver sections from EG-administered rats and examined under bright-field (Supplementary Fig. S4, upper row) and dark-field (Supplementary Fig. S4, lower row) microscopy.
In the EG2 group, large areas of cytoplasm surrounding the nuclei were negative under bright-field microscopy.
In the EG5 group, the toluidine blue-negative cytoplasm showed bright birefringent granules under dark-field microscopy, suggesting the presence of oxalate (Supplementary Fig. S4, c and f).

DNA microarray analysis of EG-administered rat liver

To further investigate the molecular mechanisms underlying transient degeneration in EG-administered rat liver, transcriptome analysis using DNA microarray was performed on liver samples from rats with and without EG administration. The top 20 most upregulated genes in the EG2 and EG5 groups are listed in Tables 2 and 3, respectively.
Table 2
Top 20 upregulated genes 2 days after ethylene glycol administration
No
Fold Change
Gene symbol
Description
1
29.89
Slc3a1
solute carrier family 3 (amino acid transporter heavy chain), member 1
2
17.19
Adh6
alcohol dehydrogenase 6 (class V)
3
16.43
LOC361914
similar to solute carrier family 7 (cationic amino acid transporter, y + system), member 12
4
11.41
Kap
kidney androgen regulated protein
5
10.84
Slc7a13
solute carrier family 7 (anionic amino acid transporter), member 13
6
9.58
Gpx3
glutathione peroxidase 3
7
9.5
RGD1307603
similar to hypothetical protein MGC37914
8
8.16
Slc7a12
solute carrier family 7 (cationic amino acid transporter, y + system), member 12
9
8.09
Prg4
proteoglycan 4
10
7.94
Sult2a1
sulfotransferase family 2 A, dehydroepiandrosterone (DHEA)-preferring, member 1
11
7.76
Havcr1
hepatitis A virus cellular receptor 1
12
7.53
Ggt1
gamma-glutamyltransferase 1
13
7.31
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
14
7.22
LOC100911413
deleted in malignant brain tumors 1 protein-like
15
7.17
Mep1a
meprin 1 alphaP
16
6.81
Slc34a1
solute carrier family 34 (type II sodium/phosphate cotransporter), member 1
17
6.26
Wfdc21
WAP four-disulfide core domain 21
18
6.13
Cd109
CD109 molecule
19
6.04
Olr1662
olfactory receptor 1662
20
5.9
Cep112
centrosomal protein 112 kDa
Table 3
Top 20 upregulated genes 5 days after ethylene glycol administration
No
Fold Change
Gene symbol
Description
1
82.88
Akr1b7
aldo–keto reductase family 1, member B7
2
27.13
Sult2a6
sulfotransferase family 2 A, dehydroepiandrosterone (DHEA)-preferring, member 6
3
19.43
Sult2a1
sulfotransferase family 2 A, dehydroepiandrosterone (DHEA)-preferring, member 1
4
12.98
RGD1307603
similar to hypothetical protein MGC37914
5
12.45
Sult2a2
sulfotransferase family 2 A, dehydroepiandrosterone (DHEA)-preferring, member 2
6
11.8
LOC100912485
alcohol sulfotransferase-like
7
11.46
Eci1
enoyl-CoA delta isomerase 1
8
11.23
Prlr
prolactin receptor
9
9.44
Otogl
otogelin-like; INTERACTS WITH valproic acid (ortholog)
10
8.02
LOC691546
similar to ubiquitin-conjugating enzyme E2R 2
11
7.38
Ech1
enoyl CoA hydratase 1, peroxisomal
12
6.75
Hamp
hepcidin antimicrobial peptide
13
6.64
Rgs16
regulator of G-protein signaling 16
14
6.6
Cyp2c12
cytochrome P450, family 2, subfamily c, polypeptide 12
15
6.45
Rps27
ribosomal protein S27
16
6.38
LOC100910150
uncharacterized LOC100910150
17
6.29
Dbp
D site of albumin promoter (albumin D-box) binding protein
18
6.27
Cabp2
calcium binding protein 2
19
6.18
Rps27l
ribosomal protein S27-like
20
5.98
Rps15al4; Rps15a
ribosomal protein S15a
In the EG2 group, both the most upregulated gene (SLC3A1) [27] and the fifth most upregulated gene (SLC7A13) [28, 29] were transporters involved in cystine uptake (Table 2). Pathway enrichment analysis showed that the “Burn wound healing” pathway, which includes genes related to apoptosis, inflammation, and collagens, ranked first (Fig. 3).
Fig. 3
Pathway enrichment analysis (EG2). Pathway enrichment analysis based on DNA microarray results from livers of rats administered EG for 2 days (EG2). The top 20 pathways most affected by EG administration are shown
Bild vergrößern
In the EG5 group, three of the five most upregulated genes (Sult2a6, Sult2a1, and Sult2a2) were associated with sulfate metabolism and conjugation, which enhance water solubility of xenobiotics for excretion [30, 31], whereas the most upregulated gene (Akr1b7) was involved in bile acid generation [32, 33] and the fourth most upregulated gene encoded a glutathione transferase (GST3π) (RGD1307603, Table 3). Pathway enrichment analysis showed that the “Burn wound healing” pathway ranked second in the EG5 groups (Fig. 4). Notably, the “cytoplasmic ribosomal proteins” pathway was ranked first in the EG5 group (Fig. 4). GO enrichment analysis also identified “Ribosome” as the top category in the EG5 group, suggesting increased ribosome synthesis following EG exposure (Supplementary Fig. S5).
Fig. 4
Pathway enrichment analysis (EG5).Pathway enrichment analysis based on DNA microarray results from livers of rats administered EG for 5 days (EG5). The top 20 pathways most affected by EG administration are shown
Bild vergrößern
Collectively, these findings indicate that cysteine transport may be upregulated as early as 2 days after EG administration. By 5 days, xenobiotic detoxification, which is consisted of chemical modifications of xenobiotics including sulfate conjugation, appeared to be induced, along with increased ribosomal biogenesis, which should be increased during proliferation that may support hepatocyte recovery from EG-induced damage (Figs. 1 and 2).

Effect of EG metabolism on the SLC7A11-Gpx4 axis in rat liver

The upregulation of SLC3A1 and SLC7A13 peaked in the EG2 group and returned to basal levels in the EG5 group (−1.37 for SLC3A1 and 1.01 for SLC7A13). In contrast, another cystine transporter, SLC7A11, was downregulated throughout EG administration (−2.07 in EG2 and −3.33 in EG5). Downregulation of this transporter, along with decreased glutathione peroxidase 4 (Gpx4), has been shown to result in ferroptosis, a form of regulated necrosis characterized by an iron-dependent increase in lipid peroxidation and reduced cellular capacity to eliminate toxic lipid peroxides [34, 35]. Gpx4 is an only Gpx that can reduce lipid peroxide and SLC7A11 is required for elevation of cellular glutathione levels through providing cysteine, a precursor of glutathione. We thus examined SLC7A11 and Gpx4 expression by immunoblotting. As shown in Fig. 5A, SLC7A11 levels showed a transient but significant decrease followed by partial recovery. In contrast, Gpx4 levels showed a time-dependent decline, reaching a significant reduction in the EG5 group compared with the control group (Fig. 5A).
Fig. 5
Decreased SLC7A11-Gpx4 axis and increased translational initiation in the liver after EG administration.(A, B, E) Immunoblotting of liver lysates from control rats (C) and EG-treated rats 2 (EG2) or 5 (EG5) days after EG administration (8 g/kg) showing levels of the indicated proteins. GAPDH and actin served as loading controls. (C) Enzymes and transporter involved in the major steps of EG metabolism and extrusion from hepatocytes. (D) Quantitative PCR (qPCR) analysis of Adh1 and Hao1 expression. The graph shows relative levels of indicated mRNAs. Each bar represents the mean ± S.D. ns, not significant; *P < 0.05; ***P < 0.001
Bild vergrößern
We next investigated whether the increased number of nucleoli (Supplementary Fig. S2B) and ribosomal gene expression (Fig. 4 and supplementary Fig. S5) were associated with increased protein synthesis. Immunoblot analysis of eukaryotic initiation factor 2α (eIF2α), whose phosphorylation correlates with inhibition of protein synthesis [36], showed decreased phosphorylation in response to EG administration, indicating increased translation (Fig. 5B). Thus, the increase in nucleolar number might lead to an increase of protein synthesis. To further evaluate the status of hepatic EG metabolism (Fig. 5C), we quantified mRNA levels of enzymes catalyzing major steps of EG metabolism in hepatocytes. As shown in Fig. 5D, both alcohol dehydrogenase (Adh1) and hydroxy acid oxidase (HAO1) were transiently upregulated during EG administration. Given that EG itself is relatively less toxic and its metabolites play major roles in toxicity, these findings are consistent with the transient hepatic damage observed after EG administration (Fig. 1). Finally, we examined 4-hydroxy-2-nonenal (4HNE)-modified protein levels, which reflect lipid peroxidation due to a decrease of SLC7A11-Gpx4 axis [37, 38], and confirmed accumulation of 4HNE-modifed proteins (Fig. 5E), indicative of lipid peroxidation.

Effect of EG metabolism on the SLC7A11-Gpx4 axis in Huh-7 human hepatoma cells

To further confirm the negative effect of EG metabolism on the SLC7A11-Gpx4 axis in hepatocytes, EG was administered to Huh-7 human hepatoma cells at concentrations (0.3, 0.6, and 1.2 M) previously reported to produce approximately 50% inhibition of KB cell viability after 3 days [20]. As shown in Fig. 6A and B, cell viability decreased in a concentration-dependent manner. Significant reductions in SLC7A11 and Gpx4 levels were also observed in 1.2 M EG group compared with those in the control group, confirming that EG exerts a negative effect on the SLC7A11-Gpx4 axis in hepatic cells (Fig. 6C). Evaluation of EG metabolism, along with solute carrier family 26 member 1 (SLC26A1), which is considered the main transporter for oxalate extrusion [39], showed induction of EG metabolism and oxalate extrusion following EG administration (Fig. 6D).
Fig. 6
Decreased SLC7A11-Gpx4 axis in Huh-7 human hepatoma cells after EG administration. Morphology (A), viability (B), immunoblotting (C), and qPCR (D) of Huh-7 cells treated with the indicated concentrations of EG for 3 days. M, mole/L. Cell viability was assessed using CCK8 assay. The graph shows relative levels of indicated proteins or mRNAs. Each bar represents the mean ± S.D. ns, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001
Bild vergrößern

Discussion

Oral administration of 8 g/kg EG resulted in metabolic acidosis (Table 1), which likely accounted for the cumulative mortality of approximately 25% observed in the experimental group 5 days after administration (2 out of 8). Increased expression of Adh1 and Hao1 was observed in both rat liver and Huh-7 cells following EG administration (Figs. 5 and 6), suggesting an increase in EG metabolites, such as GA and oxalate (Ox), and subsequent metabolic acidosis. Metabolic acidosis may also have contributed to crystal formation in the liver (Supplementary Figs. S3 and S4). However, most animals survived beyond 5 days of exposure (6 out of 8), demonstrating that the liver exhibited substantial resilience against EG toxicity.
The liver is the heaviest organ in the human body, and the liver-to-body weight ratio is strictly maintained compared with other organs [40]. Although liver weights may vary depending on the amounts of glycogen and lipids deposited in hepatocytes, only a 20–25% loss of liver weight has been reported even after 48 h of fasting [41]. Electron microscopic and histological findings revealed glycogen accumulation in hepatocytes of the EG2 group (Fig. 2 and supplementary Fig. S3), suggesting an additional mechanism underlying the decreased liver weights observed in the EG5 group. Considering the increases in AST, ALT, and LDH (Fig. 1), hepatocyte necrosis and subsequent cell loss likely contributed to the decreased liver weights. Serum AST, ALT, and LDH levels peaked in the EG2 group and declined in the EG5 group, whereas loss of liver weight became evident in the EG5 group (Fig. 1 and Table 1). This suggests a delay between hepatocyte necrosis and liver weight loss. Nevertheless, mechanisms other than hepatocyte necrosis may also underlie the observed decrease in liver weight. Since circulating serum ALB is a long-lived protein with a half-life of approximately 2–3 weeks [42], hepatocyte necrosis may not have been reflected as a significant decrease in circulating ALB in our experimental settings (Fig. 2). Alternatively, ALB synthesis may be preserved during EG administration. Notably, liver transplantation in patients with EG poisoning has been repeatedly reported, suggesting that essential liver functions are preserved even after fatal EG poisoning [4345], in spite of the fact that liver toxicity by EG is also suggest [14, 15].
Giermaziak and Orkisz conducted a detailed analysis of hepatocyte ultrastructure in rats administered EG [15]. They administered EG through a stomach tube at a dose of 5.0 mg/kg to rats and examined ultrastructure of hepatocytes 1, 5, and 14 days after the administration. Although the administration methods used by us and them differs, the doses of EG by both methods correspond to approx. 50% of the lethal dose of EG. Thus, it may be meaningful to compare the two results. They observed irregularly shaped vacuoles predominating in the cytoplasm 1 day after administration [15]. Although they reported large vacuoles with medium electron density in the cytoplasm of sinusoidal endothelial cells 5 days after administration, the main feature of hepatocytes was numerous swollen mitochondria [15]. In our study, although low electron density regions were observed in EG2 hepatocytes, these were not cytoplasmic vacuoles but portions of cytoplasm (Fig. 2, b, e, and h). The low electron density regions contained rosette-like glycogen granules in EG2 hepatocytes, associated with increased fluid content in the cytoplasm, which was reduced in EG5 hepatocytes (Fig. 2, c, f, and i). Because EG is extensively taken up by hepatocytes and metabolized to oxalate, the increased fluid content in the cytoplasm of hepatocytes could consist of EG and its metabolites, including birefringent oxalate crystals (Supplementary Fig. S4, f). One of the most remarkable differences between the observations by us and them is the morphology of mitochondria; they observed swollen mitochondria [15] whilst we did not observe any apparent changes in mitochondrial morphology (Fig. 2). Nevertheless, we do not have any rational explanation about the difference between the observations. Since morphologically normal mitochondria can be sometimes unhealthy, we are planning to examine possible mitochondrial dysfunctions in EG-administered rat kidneys.
Another microscopic finding was the increased occurrence of multiple nucleoli in the nuclei of hepatocytes from EG-administered rat liver (Fig. 2B). As demonstrated in the DNA microarray results, increased ribosomal gene expression was observed in the EG5 samples. Since the nucleolus is the site of ribosomal gene expression, nucleolar multiplication would result in increased expression of ribosomal genes, as demonstrated in this study [46, 47]. Furthermore, we observed a decreased tendency of the Ser51-phosphorylated (inactive) form of eIF2α in hepatocytes from the EG5 group, which may indicate increased translation (Fig. 5B) [48]. Because translation is a highly ATP-consuming process, glycogen accumulated in EG2 hepatocytes might have been depleted 5 days after EG administration, as indicated by PAS and PAM staining (Supplementary Fig. S3, c and f). Several pathways have been suggested to be involved in nucleolar multiplication and subsequent ribosomal biogenesis [49]. Therefore, a key future focus should be to identify the pathway responsible for EG-induced nucleolar multiplication and resultant ribosomal biogenesis, which likely play pivotal roles in hepatic recovery from EG toxicity.
Ferroptosis is an iron-dependent form of necrosis characterized by progressive lipid peroxidation, which ultimately leads to plasma membrane rupture [50, 51]. Although additional mechanisms have been proposed, loss of Gpx4-dependent reduction of lipid peroxides, along with glutathione depletion via decreases in SLC7A11 and/or Gpx4 (the SLC7A11-Gpx4 axis), was the earliest mechanism identified as a cause of ferroptosis [35, 52]. Ferroptosis has been implicated in the pathogenesis of kidney stone disease, including mechanisms involving CaOx [53, 54]. Oxalate has been repeatedly demonstrated to induce ferroptosis in renal epithelial cells in vitro [5558]; however, it remains debated whether CaOx directly induces ferroptosis or ferroptosis contributes to CaOx crystal formation and subsequent nephrolithiasis [54]. In the present study, we demonstrated a decrease in the SLC7A11-Gpx4 axis, but we did not establish that this decrease was linked to ferroptosis. However, reduced activity of the SLC7A11-Gpx4 axis likely diminishes cellular antioxidative capacity, which may be harmful to hepatocytes and contribute to the transient hepatic damage observed in this study.
Hyperoxaluria is one of the characteristic features of EG poisoning. During EG intoxication, oxalate is generated in the liver and excreted through an exchange between intracellular oxalate and extracellular sulfate mediated by SLC26A1 (also known as sulfate anion transporter-1, Sat-1) [5961]. Thus, it is plausible to speculate that sulfate incorporated into hepatocytes via SLC26A1 is utilized by sulfotransferases in EG5 hepatocytes. However, the exact role of sulfate conjugation in the elimination of EG and its metabolites remains to be established.

Conclusions

We demonstrated transient liver damage in an experimental animal model of EG poisoning. Downregulation of the SLC7A11-Gpx4 axis may contribute to EG-induced hepatic injury, while enhanced ribosomal biogenesis might play a role in recovery. These observations might contribute to not only the elucidation of EG toxicity but also forensic investigation of death by poisoning.

Declarations

Conflict of interest

The authors declare no relevant financial or non-financial interests.

Ethics approval

This study did not involve clinical studies or patient data. All animal experiments were approved by the Institutional Animal Care and Use Committee of Science of Tokyo (Permit No. A2023-080A) and performed in accordance with the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Download
Titel
Possible role of ribosome biogenesis in the recovery from transient hepatic damage caused by ethylene glycol in rats
Verfasst von
Kana Unuma
Toshihiko Aki
Nana Kobayashi
Shintaro Isa
Akihiro Tojo
Publikationsdatum
03.02.2026
Verlag
Springer Nature Singapore
Erschienen in
Forensic Toxicology
Print ISSN: 1860-8965
Elektronische ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-026-00757-4

Supplementary Information

Below is the link to the electronic supplementary material.
1.
Zurück zum Zitat Yue H, Zhao Y, Ma X, Gong J (2012) Ethylene glycol: properties, synthesis, and applications. Chem Soc Rev 41(11):4218–4244. https://doi.org/10.1039/c2cs15359aCrossRefPubMed
2.
Zurück zum Zitat Kruse JA (2012) Methanol and ethylene glycol intoxication. Crit Care Clin 28(4):661–711. https://doi.org/10.1016/j.ccc.2012.07.002CrossRefPubMed
3.
Zurück zum Zitat Leth PM, Gregersen M (2005) Ethylene glycol poisoning. Forensic Sci Int 155(2–3):179–184. https://doi.org/10.1016/j.forsciint.2004.11.012CrossRefPubMed
4.
Zurück zum Zitat Ross JA, Borek HA, Holstege CP, King JD (2022) Toxic alcohol poisoning. Emerg Med Clin North Am 40(2):327–341. https://doi.org/10.1016/j.emc.2022.01.012CrossRefPubMed
5.
Zurück zum Zitat Jacobsen D, McMartin KE (1986) Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol 1(5):309–334. https://doi.org/10.1007/BF03259846CrossRefPubMed
6.
Zurück zum Zitat Brent J (2001) Current management of ethylene glycol poisoning. Drugs 61(7):979–988. https://doi.org/10.2165/00003495-200161070-00006CrossRefPubMed
7.
Zurück zum Zitat Litovitz T (1986) The alcohols: ethanol, methanol, isopropanol, ethylene glycol. Pediatr Clin North Am 33(2):311–323. https://doi.org/10.1016/s0031-3955(16)35004-0CrossRefPubMed
8.
Zurück zum Zitat Fowles J, Banton M, Klapacz J, Shen H (2017) A toxicological review of the ethylene glycol series: commonalities and differences in toxicity and modes of action. Toxicol Lett 278:66–83. https://doi.org/10.1016/j.toxlet.2017.06.009CrossRefPubMed
9.
Zurück zum Zitat Gabow PA, Clay K, Sullivan JB, Lepoff R (1986) Organic acids in ethylene glycol intoxication. Ann Intern Med 105(1):16–20. https://doi.org/10.7326/0003-4819-105-1-16CrossRefPubMed
10.
Zurück zum Zitat Barceloux DG, Krenzelok EP, Olson K, Watson W (1999) American Academy of Clinical Toxicology practice guidelines on the treatment of ethylene glycol poisoning. Ad hoc committee. J Toxicol Clin Toxicol 37(5):537–560. https://doi.org/10.1081/clt-100102445CrossRefPubMed
11.
Zurück zum Zitat Grauer GF, Thrall MA, Henre BA, Hjelle JJ (1987) Comparison of the effects of ethanol and 4-methylpyrazole on the pharmacokinetics and toxicity of ethylene glycol in the dog. Toxicol Lett 35(2–3):307–314. https://doi.org/10.1016/0378-4274(87)90220-7CrossRefPubMed
12.
Zurück zum Zitat Hantson P, Vanbinst R, Mahieu P (2002) Determination of ethylene glycol tissue content after fatal oral poisoning and pathologic findings. Am J Forensic Med Pathol 23(2):159–161. https://doi.org/10.1097/00000433-200206000-00009CrossRefPubMed
13.
Zurück zum Zitat Scalley RD, Ferguson DR, Piccaro JC, Smart ML, Archie TE (2002) Treatment of ethylene glycol poisoning. Am Fam Physician 66(5):807–812PubMed
14.
Zurück zum Zitat Melnick RL (1984) Toxicities of ethylene glycol and ethylene glycol monoethyl ether in Fischer 344/N rats and B6C3F1 mice. Environ Health Perspect 57:147–155. https://doi.org/10.1289/ehp.8457147CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Giermaziak H, Orkisz S (1995) Effects of ethylene glycol on the ultrastructure of hepatocytes. Exp Toxicol Pathol 47(5):359–365. https://doi.org/10.1016/S0940-2993(11)80348-9CrossRefPubMed
16.
Zurück zum Zitat Gadzhiev N, Gelig V, Rodionov G, Gauhar V, Zeng G (2025) Metabolic differences in 24-hour urine parameters between calcium oxalate monohydrate and dihydrate kidney stones: a clinical study. Diagnostics. https://doi.org/10.3390/diagnostics15080994CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW et al (2012) A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490(7419):187–191. https://doi.org/10.1038/nature11556CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat du Percie Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ et al (2020) Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol 18(7):e3000411. https://doi.org/10.1371/journal.pbio.3000411CrossRef
19.
Zurück zum Zitat Yang K, Zhang X, Yang J, Huojiahemaiti X, Li X, Liu Z, et al (2024) Isovaleramide attenuates ethylene glycol poisoning-induced acute kidney injury and reduces mortality by inhibiting alcohol dehydrogenase activity in rats. Basic Clin Pharmacol Toxicol.135(5):641–54. Epub 20240926. https://doi.org/10.1111/bcpt.14084. PubMed PMID: 39324373.
20.
Zurück zum Zitat Mochida K, Gomyoda M (1987) Toxicity of ethylene glycol, diethylene glycol, and propylene glycol to human cells in culture. Bull Environ Contam Toxicol 38(1):151–153. https://doi.org/10.1007/BF01606573CrossRefPubMed
21.
Zurück zum Zitat Unuma K, Aki T, Funakoshi T, Yoshida K, Uemura K (2013) Cobalt protoporphyrin accelerates TFEB activation and lysosome reformation during LPS-induced septic insults in the rat heart. PLoS One 8(2):e56526. https://doi.org/10.1371/journal.pone.0056526CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Tojo A, Sekine T, Nakajima N, Hosoyamada M, Kanai Y, Kimura K et al (1999) Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney. J Am Soc Nephrol 10(3):464–471. https://doi.org/10.1681/ASN.V103464CrossRefPubMed
23.
Zurück zum Zitat Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O et al (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10(1):1523. https://doi.org/10.1038/s41467-019-09234-6CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3(6):1101–1108. https://doi.org/10.1038/nprot.2008.73CrossRefPubMed
25.
Zurück zum Zitat Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680–685. https://doi.org/10.1038/227680a0CrossRefPubMed
26.
Zurück zum Zitat Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76(9):4350–4354. https://doi.org/10.1073/pnas.76.9.4350CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Pras E, Sood R, Raben N, Aksentijevich I, Chen X, Kastner DL (1996) Genomic organization of SLC3A1, a transporter gene mutated in cystinuria. Genomics 36(1):163–167. https://doi.org/10.1006/geno.1996.0437CrossRefPubMed
28.
Zurück zum Zitat Nagamori S, Wiriyasermkul P, Guarch ME, Okuyama H, Nakagomi S, Tadagaki K et al (2016) Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT/SLC3A1. Proc Natl Acad Sci U S A 113(3):775–780. https://doi.org/10.1073/pnas.1519959113CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Olschok K, Vester U, Lahme S, Kurth I, Eggermann T (2018) No evidence for point mutations in the novel renal cystine transporter AGT1/SLC7A13 contributing to the etiology of cystinuria. BMC Nephrol 19(1):278. https://doi.org/10.1186/s12882-018-1080-5CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Suiko M, Kurogi K, Hashiguchi T, Sakakibara Y, Liu MC (2017) Updated perspectives on the cytosolic sulfotransferases (SULTs) and SULT-mediated sulfation. Biosci Biotechnol Biochem 81(1):63–72. https://doi.org/10.1080/09168451.2016.1222266CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Coughtrie MWH (2016) Function and organization of the human cytosolic sulfotransferase (SULT) family. Chem Biol Interact 259:2–7. https://doi.org/10.1016/j.cbi.2016.05.005CrossRefPubMed
32.
Zurück zum Zitat Schmidt DR, Schmidt S, Holmstrom SR, Makishima M, Yu RT, Cummins CL et al (2011) AKR1B7 is induced by the farnesoid X receptor and metabolizes bile acids. J Biol Chem 286(4):2425–2432. https://doi.org/10.1074/jbc.M110.181230CrossRefPubMed
33.
Zurück zum Zitat Suh JH, Cheon I, Jung HJ, Lee SH, Heo MJ, DeBerge M et al (2025) Bile acid regulation of xenobiotic nuclear receptors on the expressions of orosomucoids in the liver. Am J Physiol Endocrinol Metab 328(6):E940–E951. https://doi.org/10.1152/ajpendo.00417.2024CrossRefPubMed
34.
Zurück zum Zitat Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M et al (2014) Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife 3:e02523. https://doi.org/10.7554/eLife.02523CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156(1–2):317–331. https://doi.org/10.1016/j.cell.2013.12.010CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Sarre TF (1989) The phosphorylation of eukaryotic initiation factor 2: a principle of translational control in mammalian cells. Biosystems 22(4):311–325. https://doi.org/10.1016/0303-2647(89)90053-1CrossRefPubMed
37.
Zurück zum Zitat Ayala A, Munoz MF, Arguelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014:360438. https://doi.org/10.1155/2014/360438CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Feng H, Stockwell BR (2018) Unsolved mysteries: how does lipid peroxidation cause ferroptosis? PLoS Biol 16(5):e2006203. https://doi.org/10.1371/journal.pbio.2006203CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Quondamatteo F, Krick W, Hagos Y, Kruger MH, Neubauer-Saile K, Herken R, et al. (2006) Localization of the sulfate/anion exchanger in the rat liver. Am J Physiol Gastrointest Liver Physiol.290(5):G1075–81. Epub 20051215. https://doi.org/10.1152/ajpgi.00492.2005. PubMed PMID: 16357056.
40.
Zurück zum Zitat Michalopoulos GK (2017) Hepatostat: liver regeneration and normal liver tissue maintenance. Hepatology 65(4):1384–1392. https://doi.org/10.1002/hep.28988CrossRefPubMed
41.
Zurück zum Zitat Bezborodkina NN, Chestnova AY, Vorobev ML, Kudryavtsev BN (2016) Glycogen content in hepatocytes is related with their size in normal rat liver but not in cirrhotic one. Cytometry A 89(4):357–364. https://doi.org/10.1002/cyto.a.22811CrossRefPubMed
42.
Zurück zum Zitat Peters T Jr. (1985) Serum albumin. Adv Protein Chem 37:161–245. https://doi.org/10.1016/s0065-3233(08)60065-0CrossRefPubMed
43.
Zurück zum Zitat Dy-Liacco MS, Tuttle-Newhall EJ, Collins BH, Kuo PC (2003) Liver transplantation from a cadaver donor with ethylene-glycol-induced brain death. Transplantation 75(7):1056. https://doi.org/10.1097/01.TP.0000058773.88045.11CrossRefPubMed
44.
Zurück zum Zitat Burman A, Watson CJE, Kosmoliaptsis V (2017) Ethylene glycol poisoning should not contraindicate liver donation. Transplant Direct 3(10):e212. https://doi.org/10.1097/TXD.0000000000000729CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Matar AJ, Magliocca JF, Kitchens WH (2022) Successful liver transplantation from a deceased donor after ethylene glycol ingestion: a case report and review of the literature of organ donation from poisoned donors. Transplant Proc 54(1):128–134. https://doi.org/10.1016/j.transproceed.2021.11.015CrossRefPubMed
46.
Zurück zum Zitat Hori Y, Engel C, Kobayashi T (2023) Regulation of ribosomal RNA gene copy number, transcription and nucleolus organization in eukaryotes. Nat Rev Mol Cell Biol 24(6):414–429. https://doi.org/10.1038/s41580-022-00573-9CrossRefPubMed
47.
Zurück zum Zitat Jiao L, Liu Y, Yu XY, Pan X, Zhang Y, Tu J et al (2023) Ribosome biogenesis in disease: new players and therapeutic targets. Signal Transduct Target Ther 8(1):15. https://doi.org/10.1038/s41392-022-01285-4CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Wang X, Proud CG (2022) The role of eIF2 phosphorylation in cell and organismal physiology: new roles for well-known actors. Biochem J 479(10):1059–1082. https://doi.org/10.1042/BCJ20220068CrossRefPubMed
49.
Zurück zum Zitat Farley-Barnes KI, McCann KL, Ogawa LM, Merkel J, Surovtseva YV, Baserga SJ (2018) Diverse regulators of human ribosome biogenesis discovered by changes in nucleolar number. Cell Rep 22(7):1923–1934. https://doi.org/10.1016/j.celrep.2018.01.056CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Berndt C, Alborzinia H, Amen VS, Ayton S, Barayeu U, Bartelt A et al (2024) Ferroptosis in health and disease. Redox Biol 75:103211. https://doi.org/10.1016/j.redox.2024.103211CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266–282. https://doi.org/10.1038/s41580-020-00324-8CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Wang SJ, Li D, Ou Y, Jiang L, Chen Y, Zhao Y et al (2016) Acetylation is crucial for p53-mediated ferroptosis and tumor suppression. Cell Rep 17(2):366–373. https://doi.org/10.1016/j.celrep.2016.09.022CrossRefPubMedPubMedCentral
53.
Zurück zum Zitat Tang K, Ye T, He Y, Ba X, Xia D, Peng E et al (2025) Ferroptosis, necroptosis, and pyroptosis in calcium oxalate crystal-induced kidney injury. Biochimica et Biophysica Acta (BBA) 1871(5):167791. https://doi.org/10.1016/j.bbadis.2025.167791CrossRef
54.
Zurück zum Zitat Yang J, Wu W, Amier Y, Li X, Wan W, Xun Y et al (2024) Ferroptosis and its emerging role in kidney stone formation. Mol Biol Rep 51(1):314. https://doi.org/10.1007/s11033-024-09259-1CrossRefPubMedPubMedCentral
55.
Zurück zum Zitat Xie J, Ye Z, Li L, Xia Y, Yuan R, Ruan Y et al (2022) Ferrostatin‑1 alleviates oxalate‑induced renal tubular epithelial cell injury, fibrosis and calcium oxalate stone formation by inhibiting ferroptosis. Mol Med Rep. https://doi.org/10.3892/mmr.2022.12772CrossRefPubMedPubMedCentral
56.
Zurück zum Zitat He Z, Liao W, Song Q, Li B, Liu J, Xiong Y et al (2021) Role of ferroptosis induced by a high concentration of calcium oxalate in the formation and development of urolithiasis. Int J Mol Med 47(1):289–301. https://doi.org/10.3892/ijmm.2020.4770CrossRefPubMed
57.
Zurück zum Zitat Song Q, Liao W, Chen X, He Z, Li D, Li B et al (2021) Oxalate activates autophagy to induce ferroptosis of renal tubular epithelial cells and participates in the formation of kidney stones. Oxid Med Cell Longev 2021(1):6630343. https://doi.org/10.1155/2021/6630343CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Su X, Song C, He Z, Song Q, Meng L, Dong C et al (2024) Ambra1 in exosomes secreted by HK-2 cells damaged by supersaturated oxalate induce mitophagy and autophagy-ferroptosis in normal HK-2 cells to participate in the occurrence of kidney stones. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1871(1):119604. https://doi.org/10.1016/j.bbamcr.2023.119604CrossRefPubMed
59.
Zurück zum Zitat Alper SL, Sharma AK (2013) The SLC26 gene family of anion transporters and channels. Mol Aspects Med 34(2–3):494–515. https://doi.org/10.1016/j.mam.2012.07.009CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Breljak D, Brzica H, Vrhovac I, Micek V, Karaica D, Ljubojevic M et al (2015) In female rats, ethylene glycol treatment elevates protein expression of hepatic and renal oxalate transporter sat-1 (Slc26a1) without inducing hyperoxaluria. Croat Med J 56(5):447–459. https://doi.org/10.3325/cmj.2015.56.447.PubMedPMID:26526882;PubMedCentralPMCID:PMCPMC4655930CrossRefPubMedPubMedCentral
61.
Zurück zum Zitat Sun LL, He HY, Li W, Jin WL, Wei YJ (2024) The solute carrier transporters (SLCs) family in nutrient metabolism and ferroptosis. Biomark Res 12(1):94. https://doi.org/10.1186/s40364-024-00645-2CrossRefPubMedPubMedCentral

Neu im Fachgebiet Rechtsmedizin

Praktische forensische Todeszeitschätzung am Fundort im frühen postmortalen Intervall

Die forensische Todeszeitschätzung im frühen postmortalen Intervall dient der Eingrenzung eines wahrscheinlichen Zeitintervalls des Versterbens einer Person. Zur Anwendung kommt die sog. Komplexmethode, die sich aus der temperaturbasierten …

KI-basierte Bilder zu forensischen Demonstrationszwecken

Die Wissenschaft lebt vom Sehen, davon, dass das, was unaussprechlich ist, sichtbar (gemacht) wird – in Bildern, Skizzen, Simulationen, Schemata. Wer sich mit nichtnatürlichen Todesfällen befasst, bewegt sich stets an der Grenze zwischen …

Alternativer Ansatz zur Ableitung der Abbaukinetik von Methamphetamin und Tetrahydrocannabinol aus Blutproben von Straßenverkehrsdelikten

In den letzten 20 Jahren sind im Freistaat Sachsen, der an die Tschechische Republik grenzt, die Zahl der drogenbezogenen Straftaten, die Menge an beschlagnahmten Btm durch die Zoll- und Polizeibehörden sowie der Konsum von Betäubungsmitteln nach …

Diskriminierungserfahrungen und -wahrnehmung bei Rechtsmediziner*innen und Medizinstudierenden

Die medizinische Wissenschaft fordert längst, Sensibilität für Diskriminierungseffekte u. a. im ärztlichen Sprachgebrauch und in der medizinischen Ausbildung aufzubauen [ 9 , 20 , 22 , 24 ]. Bisherige Studien zu Diskriminierungserfahrungen im …